Type 2 Diabetes (T2D) Susceptibility Loci and Beta Cell Defects in Islets (ISLs) from Non-Diabetic (ND) and T2D Subjects

被引:0
|
作者
Del Guerra, Silvia
Groves, Christopher
D'Aleo, Valentina
Lupi, Roberto
Maccarthy, Mark
Marchetti, Piero
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1405-P
引用
收藏
页码:A387 / A387
页数:1
相关论文
共 50 条
  • [41] Findings at Diagnosis of Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D): The Pediatric Diabetes Consortium (PDC)
    Klingensmith, Georgeanna J.
    Willi, Steven M.
    Cengiz, Eda
    Wood, Jamie
    Tamborlane, William V.
    Lee, Joyce M.
    Haro, Heidi
    Beck, Roy W.
    Kollman, Craig
    Ruedy, Katrina
    Connor, Crystal
    DIABETES, 2014, 63 : A391 - A391
  • [42] Pancreatic Islets in Short Duration Type 2 Diabetes (T2D) Show Macrophage Infiltration and Increased Inflammatory Signaling
    Walker, John T.
    Shrestha, Shristi
    Prasad, Nripesh
    Richardson, Tiffany
    Aramandla, Radhika
    Poffenberger, Greg
    Bottino, Rita
    Brissova, Marcela
    Powers, Alvin C.
    DIABETES, 2018, 67
  • [43] Weight Loss Strategies and Changes in Body Weight among Subjects with Type 2 Diabetes (T2D) in the US
    Wang, Yiting
    Lopez, Janice
    Zhu, Vivienne
    Bolge, Susan C.
    Rupnow, Marcia
    Bailey, Robert A.
    Stang, Paul E.
    DIABETES, 2015, 64 : A429 - A429
  • [44] Inflammatory and Apoptotic Markers in Plasma and Renal Function in Subjects with Type 2 Diabetes (T2D) and without Proteinuria
    Gohda, Tomohito
    Niewczas, Monika A.
    Walker, William H.
    Crabtree, Gordon S.
    Burman, Aaron M.
    Smiles, Adam M.
    Warram, James H.
    Krolewski, Andrzej S.
    DIABETES, 2009, 58 : A215 - A215
  • [45] Diabetes Distress, Depression, Perceived Stress, and Medication Adherence in Type 2 Diabetes (T2D)
    Mustafiz, Fayel
    Hoogendoorn, Claire J.
    Gonzalez, Jeffrey S.
    DIABETES, 2022, 71
  • [46] Bromocriptine-QR (BQR) Reduces Hypertriglyceridemia (HTG) in Hypertensive Type 2 Diabetes (T2D) Subjects
    Chamarthi, Bindu
    Ezrokhi, Michael
    Cincotta, Anthony H.
    DIABETES, 2020, 69
  • [47] TYPE 2 DIABETES PATIENTS SUBCLASSIFICATION ANALYSIS: PERSONALIZED T2D CARE OF DORZAGLIATIN
    Feng, L.
    Chen, C.
    Chen, L.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A87 - A87
  • [48] Circulating Metabolomic Biomarkers of Glycemic Control in Youth with Type 2 Diabetes (T2D)
    Chen, Zsu-Zsu
    Lu, Chang
    Shi, Xu
    Zheng, Shuning
    Wolfs, Danielle
    Bjornstad, Petter
    Gerszten, Robert E.
    Isganaitis, Elvira M.
    DIABETES, 2023, 72
  • [49] Effort Reward Imbalance (ERI) among Workers with Type 2 Diabetes (T2D)
    Olesen, Kasper
    Cleal, Bryan
    Willaing, Ingrid
    DIABETES, 2016, 65 : A219 - A219
  • [50] Dapagliflozin and measures of cardiovascular autonomic function in patients with type 2 diabetes (T2D)
    Ang, Lynn
    Kidwell, Kelley M.
    Dillon, Brendan
    Reiss, Jacob
    Fang, Fang
    Leone, Virginia
    Mizokami-Stout, Kara
    Pop-Busui, Rodica
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (08)